INTERNATIONAL PATENT: NITRASE THERAPEUTICS, INC. FILES APPLICATION FOR "NY39 ALPHA-SYNUCLEIN ANTIBODIES AND METHODS OF USE THEREOF"

GENEVA, Oct. 15 -- NITRASE THERAPEUTICS, INC. (1000 Marina Blvd, Suite 200Brisbane, CA 94005) filed a patent application (PCT/US2025/022671) for "NY39 ALPHA-SYNUCLEIN ANTIBODIES AND METHODS OF USE THEREOF" on Apr 02, 2025. With publication no. WO/2025/212730, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GRISWOLD-PRENNER, Irene (Nitrase Therapeutics, Inc.1000 Marina Blvd, Suite 200Brisbane, CA 94005), KASHYAP, Arun (Nitrase Therapeutics, Inc.1000 Marina Blvd, Suite 200Brisbane, CA 94005), SHAHIDI-LATHAM, Sheerin (Nitras...